Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Us Securely

Fees | Join Our Practice

A vibrant watercolor-style digital painting showing an abstract red and orange prostate gland on the left and a white aspirin tablet on the right, surrounded by swirling yellow and orange hues, symbolizing the potential connection between aspirin use and prostate health.

Aspirin, commonly used to prevent cardiovascular disease, may also influence prostate health. Understanding this relationship helps men make thoughtful choices about preventive care and overall wellness. Let’s explore the connection between aspirin use, prostate health, and its broader health impacts.

Aspirin and Prostate Cancer

Observational studies [1-5] suggest aspirin may help reduce the risk of developing prostate cancer and decrease its severity. Its anti-inflammatory properties play a key role, potentially limiting the chronic inflammation linked to cancer growth.

Regular aspirin use might provide added protection, especially after a prostate cancer diagnosis. This benefit highlights the value of consistent intake over occasional use. The anti-inflammatory mechanism of aspirin is believed to reduce cellular stress, lowering the chances of mutations and abnormal cell growth commonly associated with prostate cancer.

Additionally, aspirin could slow cancer progression by inhibiting platelet aggregation, a process crucial for cancer cell spread. While aspirin is promising, it’s essential to note that its benefits may vary individually, emphasizing the importance of tailored medical guidance.

Aspirin and Benign Prostatic Hyperplasia (BPH)

Evidence regarding aspirin’s effect on BPH, a common non-cancerous enlargement of the prostate, remains unclear [6-8]. Some studies propose that aspirin’s anti-inflammatory action could ease symptoms of BPH, such as urinary discomfort, urgency, or frequency. Reducing inflammation might alleviate the swelling and discomfort associated with BPH. However, findings are preliminary, and further research is needed to clarify aspirin’s role in managing BPH effectively.

Aspirin and Colon Cancer

Apart from prostate health, aspirin demonstrates significant potential in colon cancer prevention [9-13]. Its anti-inflammatory properties can inhibit polyp formation in the colon, thereby lowering the risk of colon cancer. Polyps, benign growths in the colon lining, can develop into cancer if left untreated.

Regular aspirin intake has been shown to reduce the occurrence and recurrence of these polyps significantly. Many medical guidelines now support aspirin use for individuals with elevated colon cancer risks, such as those with a family history or previous polyp findings, highlighting aspirin’s broader protective effects beyond cardiovascular and prostate health.

Other Health Benefits of Aspirin

Aspirin offers additional well-known health benefits that contribute to overall wellness:

  • Cardiovascular Protection: Aspirin prevents blood clots, reducing heart attack and stroke risk. It’s an essential preventive measure for individuals with cardiovascular risk factors such as hypertension, high cholesterol, or diabetes. Regular aspirin use is particularly beneficial in individuals who’ve experienced a previous cardiovascular event, significantly reducing the likelihood of recurrent incidents.
  • Anti-inflammatory Effects: Aspirin reduces inflammation, aiding conditions like arthritis and certain autoimmune disorders, enhancing comfort and quality of life. By lowering inflammation levels, aspirin can also potentially reduce chronic pain and discomfort, improving daily function and overall well-being.

Potential Harms and Risks

Despite its benefits, aspirin carries potential risks:

  • Bleeding Risks: Aspirin thins the blood, increasing gastrointestinal bleeding or stroke risk, especially in older adults or those with bleeding disorders. Regular users should remain vigilant for symptoms such as unusual bruising, prolonged bleeding from minor wounds, or blood in stools, promptly seeking medical advice if such signs occur.
  • Stomach and Digestive Issues: Long-term use can irritate the stomach lining, potentially causing ulcers, gastritis, or gastrointestinal discomfort. Individuals with a history of ulcers or digestive problems should consult a physician to determine whether aspirin is appropriate.
  • Medication Interactions: Aspirin may negatively interact with blood thinners, NSAIDs, corticosteroids, and other medications, highlighting the importance of personalized medical guidance. A thorough review of current medications with a specialist can help prevent harmful interactions and maximize aspirin’s potential benefits.

Why Holistic, Individualized Care Matters

Like all medical decisions, choosing to use aspirin, especially for prostate and colon health, means considering many interconnected health factors. This includes prevention, medication, lifestyle changes, and regular follow-up. A thoughtful and personalized approach helps ensure safety, effectiveness, and better long-term results.

Key Takeaways

  • Regular aspirin use may qualitatively reduce the risk of prostate and colon cancer.
  • Mixed evidence on potential benefits for BPH symptoms.
  • Aspirin provides cardiovascular and anti-inflammatory advantages.
  • Potential harms, such as bleeding and digestive issues, necessitate careful evaluation.
  • Personalized consultation ensures balanced, thoughtful health decisions.

Choosing aspirin involves carefully weighing its comprehensive benefits and potential risks, underscoring the importance of individualized, informed medical advice.

Dr. Tashko

For Personalized Preventative and Wellness Care,
Join Dr. Tashko’s Practice!
Logo for Endocrine ABIM board-certified.

References

  1. Long-Term Aspirin Use and the Risk of Total, High-Grade, Regionally Advanced and Lethal Prostate Cancer in a Prospective Cohort of Health Professionals, 1988-2006. Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL. International Journal of Cancer. 2011;128(10):2444-52. doi:10.1002/ijc.25811.
  2. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study. Downer MK, Allard CB, Preston MA, et al. European Urology. 2017;72(5):821-827. doi:10.1016/j.eururo.2017.01.044.
  3. Effect of Aspirin on Incidence, Recurrence, and Mortality in Prostate Cancer Patients: Integrating Evidence From Randomized Controlled Trials and Real-World Studies. Ma S, Xia W, Wu B, et al. European Journal of Clinical Pharmacology. 2023;79(11):1475-1503. doi:10.1007/s00228-023-03556-7.
  4. Effect of Long Term Aspirin Use on the Incidence of Prostate Cancer: A Systematic Review and Meta-Analysis. Sauer CM, Myran DT, Costentin CE, et al. Critical Reviews in Oncology/Hematology. 2018;132:66-75. doi:10.1016/j.critrevonc.2018.09.013.
  5. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study. Hurwitz LM, Joshu CE, Barber JR, et al. Cancer Epidemiology, Biomarkers & Prevention. 2019;28(3):563-569. doi:10.1158/1055-9965.EPI-18-0965.
  6. Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Benign Prostatic Hyperplasia-Related Outcomes and Nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Sutcliffe S, Grubb Iii RL, Platz EA, et al. BJU International. 2012;110(7):1050-9. doi:10.1111/j.1464-410X.2011.10867.x.
  7. Indications for and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial. Schenk JM, Calip GS, Tangen CM, et al. American Journal of Epidemiology. 2012;176(2):156-63. doi:10.1093/aje/kwr524.
  8. Protective Association Between Nonsteroidal Antiinflammatory Drug Use and Measures of Benign Prostatic Hyperplasia. St Sauver JL, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ. American Journal of Epidemiology. 2006;164(8):760-8. doi:10.1093/aje/kwj258.
  9. Aspirin and the Risk of Colorectal and Other Digestive Tract Cancers: An updated Meta-Analysis Through 2019. Bosetti C, Santucci C, Gallus S, Martinetti M, La Vecchia C. Annals of Oncology. 2020;31(5):558-568. doi:10.1016/j.annonc.2020.02.012.
  10. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Shaukat A, Kahi CJ, Burke CA, et al. The American Journal of Gastroenterology. 2021;116(3):458-479. doi:10.14309/ajg.0000000000001122.
  11. Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway. Nafisi S, Støer NC, Veierød MB, et al. The American Journal of Gastroenterology. 2024;119(7):1402-1411. doi:10.14309/ajg.0000000000002695.
  12. Aspirin Chemoprevention in Colorectal Cancer: Network Meta-Analysis of Low, Moderate, and High Doses. Shah D, Di Re A, Toh JWT. The British Journal of Surgery. 2023;110(12):1691-1702. doi:10.1093/bjs/znad231.
  13. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Guirguis-Blake JM, Evans CV, Perdue LA, Bean SI, Senger CA. JAMA. 2022;327(16):1585-1597. doi:10.1001/jama.2022.3337.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is a board-certified endocrinologist based in Montgomery County, Maryland. He is uniquely certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice offers comprehensive, root-cause-focused metabolic and endocrine care, available both virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to optimize long-term health outcomes.

Published

By

Gerti Tashko, MD
Categorized as , , ,